Safety and efficacy of gemcitabine or pemetrexed in combination with a platinum in patients with non-small-cell lung cancer and prior interstitial lung diseaseMOON KI CHOI; JUNG YONG HONG; PARK, Keunchil et al.Cancer chemotherapy and pharmacology. 2014, Vol 73, Num 6, pp 1217-1225, issn 0344-5704, 9 p.Article

Economic analysis of a randomized phase III trial of gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer (Italian GEMVIN3/NCIC CTG BR14 trial)NEIL REAUME, M; LEIGHL, Natasha B; PERRONE, Francesco et al.Lung cancer. 2013, Vol 82, Num 1, pp 115-120, issn 0169-5002, 6 p.Article

Phase II study of erlotinib for chemotherapy-naïve patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum doubletsDAE HO LEE; KIM, Sang-We; SUH, Cheolwon et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 1, pp 35-39, issn 0344-5704, 5 p.Article

A retrospective analysis of outcomes across histological subgroups in a three-arm phase III trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin for advanced non-small cell lung cancerTREAT, Joseph; EDELMAN, Martin J; BELANI, Chandra P et al.Lung cancer. 2010, Vol 70, Num 3, pp 340-346, issn 0169-5002, 7 p.Article

Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA-IIIA non-small-cell lung cancerKAWAMURA, Masafumi; EGUCHI, Keisuke; IZUMI, Yotaro et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 4, pp 495-501, issn 0344-5704, 7 p.Article

Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancerBELANI, C. P; DAKHIL, S; WATERHOUSE, D. M et al.Annals of oncology. 2007, Vol 18, Num 1, pp 110-115, issn 0923-7534, 6 p.Article

Comparative Effectiveness of Three Platinum-Doublet Chemotherapy Regimens in Elderly Patients With Advanced Non-Small Cell Lung CancerJUNYA ZHU; SHARMA, Dhruv B; CHEN, Aileen B et al.Cancer. 2013, Vol 119, Num 11, pp 2048-2060, issn 0008-543X, 13 p.Article

A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancerTREAT, J. A; GONIN, R; OBASAJU, C. K et al.Annals of oncology. 2010, Vol 21, Num 3, pp 540-547, issn 0923-7534, 8 p.Article

Erlotinib in First-line Therapy for Non-small Cell Lung Cancer: A Prospective Phase II StudyDAE RO CHOI; DAE HO LEE; CHOI, Chang-Min et al.Anticancer research. 2011, Vol 31, Num 10, pp 3457-3462, issn 0250-7005, 6 p.Article